Rotating night shifts and risk of breast cancer in women participating in the nurses' health study

Journal of the National Cancer Institute

Volumn 93, Issue 20, 2001, Pages 1563-1568

  Schernhammer, Eva S ^a,d   Laden, Francine ^a,b   Speizer, Frank E ^a,b   Willett, Walter C ^a,b   Hunter, David J ^a,c   Kawachi, Ichiro ^a,b   Colditz, Graham A ^a,b,d  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c HARVARD CENTER FOR CANCER PREVENTION   (United States)

^d CHANNING LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MELATONIN;

ARTICLE; BREAST CANCER; CALCULATION; CANCER INCIDENCE; CANCER RISK; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; LIGHT EXPOSURE; MAJOR CLINICAL STUDY; MEDICAL DOCUMENTATION; MEDICAL INFORMATION; MULTIVARIATE ANALYSIS; NIGHT WORK; NURSE; PRIORITY JOURNAL; REGRESSION ANALYSIS; SHIFT WORKER; STATISTICAL ANALYSIS;

EID: 0035904335     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/93.20.1563     Document Type: Article

References (56)

1. Prospective study of shift work and risk of coronary heart disease in women
2. Increased breast cancer risk among women who work predominantly at night
3. Melatonin increases p53 and p21WAF1 expression in MCF-7 human breast cancer cells in vitro
4. Melatonin: Receptor-mediated events that may affect breast and other steroid hormone-dependent cancers
5. Influence of melatonin on invasive and metastatic properties of MCF-7 human breast cancer cells
6. Breast cancer and electromagnetic fields-a review
7. Serial transplants of DMBA-induced mammary tumors in Fischer rats as a model system for human breast cancer
8. Nocturnal urinary 6-sulphatoxymelatonin excretion is decreased in primary breast cancer patients compared to age-matched controls and shows negative correlation with tumor-size
9. A sequential treatment regimen with melatonin and all-trans retinoic acid induces apoptosis in MCF-7 tumour cells
10. The role of granulocyte-macrophage-colony stimulating factor, cortisol, and melatonin in the regulation of the circadian rhythms of peripheral blood cells in healthy volunteers and patients with breast cancer
11. Light suppresses melatonin secretion in humans
12. The melatonin hypothesis: Electric power and breast cancer
13. Incidence of breast cancer in Norwegian female radio and telegraph operators
14. Incidence of cancer among Finnish airline cabin attendants, 1967-92
15. Breast cancer in female flight attendants
16. The tumor promoting effect of constant light exposure on diethylnitrosamine-induced hepatocarcinogenesis in rats
17. Melatonin and colon carcinogenesis. I. Inhibitory effect of melatonin on development of intestinal tumors induced by 1,2-dimethylhydrazine in rats
18. Melatonin and colon carcinogenesis. II. Intestinal melatonin-containing cells and serum melatonin level in rats with 1,2-dimethylhydrazine-induced colon tumors
19. Melatonin content in plasma and large intestine of patients with colorectal carcinoma before and after surgery
20. Nocturnal urinary 6-sulfatoxymelatonin and proliferating cell nuclear antigen-immunopositive tumor cells show strong positive correlations in patients with gastrointestinal and lung cancer
21. Effects of melatonin on N-nitroso-N-methylurea-induced carcinogenesis in rats and mutagenesis in vitro (Ames test and COMET assay)
22. Melatonin inhibition of cancer growth in vivo involves suppression of tumor fatty acid metabolism via melatonin receptor-mediated signal
23. Melatonin administration in tumor-bearing mice (intact and pinealectomized) in relation to stress, zinc, thymulin and IL-2
24. The oncostatic action of melatonin in an ovarian carcinoma cell line
25. Melatonin receptors in PC3 human prostate tumor cells
26. Melatonin-induced inhibition of proliferation and G1/S cell cycle transition delay of human choriocarcinoma JAr cells: Possible involvement of MT2 (MEL1B) receptor
27. Melatonin does not inhibit estradiol-stimulated proliferation in MCF-7 and BG-1 cells
28. Melatonin in humans
29. Role of pineal gland in aetiology and treatment of breast cancer
30. p53 and human cancers
31. Dietary fat and the risk of breast cancer
32. A prospective study of postmenopausal estrogen therapy and coronary heart disease
33. Reproducibility and validity of a semiquantitative food frequency questionnaire
34. Test of the National Death Index
35. Test of the National Death Index and Equifax Nationwide Death Search
36. Relative weight and risk of breast cancer among premenopausal women
37. Epidemiologic analysis with a programmable calculator
38. Relation of pooled logistic regression to time dependent Cox regression analysis: The Framingham Heart Study
39. Correlations between estrogen receptor, progesterone receptor, and patient characteristics in human breast cancer
40. Photic regulation of melatonin in humans: Ocular and neural signal transduction
41. Conservation of photoperiod-responsive mechanisms in humans
42. An evaluation of scheduled bright light and darkness on rotating shiftworkers: Trial and limitations
43. Inverse association between breast cancer incidence and degree of visual impairment in Finland
44. Melatonin receptors: Localization, molecular pharmacology and physiological significance
45. Melatonin receptors: Are there multiple subtypes?
46. Melatonin directly scavenges hydrogen peroxide: A potentially new metabolic pathway of melatonin biotransformation
47. Validation of questionnaire information on risk factors and disease outcomes in a prospective cohort study of women
48. Electric blanket use and breast cancer in the Nurses' Health Study
49. Does nondifferential misclassification of exposure always bias a true effect toward the null value?
50. Twenty-four-hour melatonin and core body temperature rhythms: Their adaptation in night workers
51. Effect of stimulation of endogenous melatonin secretion during constant light exposure on 6-sulphatoymelatonin rhythmicity in rats
52. Short and long-term adjustment of circadian rhythms in 'permanent' night nurses
53. Electric power, pineal function, and the risk of breast cancer
54. Melatonin affects the metabolism of the beta-amyloid precursor protein in different cell types
55. Do plasma melatonin concentrations decline with age?